Highly Effective Poly(Ethylene Glycol) Architectures for Specific Inhibition of Immune Receptor Activation

Architectural features of synthetic ligands were systematically varied to optimize inhibition of mast cell degranulation initiated by multivalent crossing of IgE−receptor complexes. A series of ligands were generated by end-capping poly(ethylene glycol) (PEG) polymers and amine-based dendrimers with the hapten 2,4-dinitrophenyl (DNP). These were used to explore the influence of polymeric backbone length, valency, and hapten presentation on binding to anti-DNP IgE and inhibition of stimulated activation of RBL cells. Monovalent MPEG5000−DNP (IC50 = 50 nM), bivalent DNP−PEG3350−DNP (IC50 = 8 nM), bismonovalent MPEG5000−DNP2 (IC50 = 20 nM), bisbivalent DNP2−PEG3350−DNP2 (IC50 = 3nM) and DNP4−dendrimer ligands (IC50 = 50 nM) all effectively inhibit cellular activation caused by multivalent antigen, DNP−bovine serum albumin. For different DNP ligands, we provide evidence for more effective inhibition due to (i) preferential formation of intra-IgE cross-links by bivalent ligands of sufficient length, (ii) self-association of monovalent ligands with longer tails, and (iii) higher probability of binding for bisvalent ligands. We also show that larger DNP16−dendrimers of higher valency trigger degranulation by cross-linking IgE−receptor complexes, whereas smaller DNP−dendrimers are inhibitory. Thus, features of synthetic ligands can be manipulated to control receptor occupation, aggregation, and inhibition of the cellular response.